COMPASS Research Group · UCL 🧭

The UCL #ProstateMRI Masterclass 2025 is done!

2 days, 4 interactive MRI breakouts, many practical sessions, MDT cases & a seriously engaged global audience

Huge thanks to our speakers, breakout supervisors, sponsors, organising team and every delegate who joined us💙

#UroSoMe

🎙️ New on #UroOncMinute: @veerukasi & @Adam_Weiner535 on #PRIME at #EAU26

bpMRI detected clinically significant prostate cancer at non-inferior rates to mpMRI ‼️

No contrast. Less time. Wider access.

🎧 Listen/watch: urologytimes.com/view/the-uroon…

📄 JAMA: jamanetwork.com/journals/jama/…

🚨 JUST PUBLISHED in @EUplatinum

Updated meta-analysis (40 studies, 9,400+ patients) shows #bpMRI is NONINFERIOR to #mpMRI for clinically significant #PCa

🌟 First to include #PRIME trial data; proud to be part of this 🌏 collaboration

📄 Read HERE: sciencedirect.com/science/articl…

Proud to share this @UCL Philanthropy feature on our work in #PCa diagnosis.

#PRIME showed we can halve MRI scan times, potentially doubling global capacity to 8 million scans/year.

⏭️ Now, PARADIGM will test whether AI can match expert radiologists.

🔗 advancement.ucl.ac.uk/accelerating-t…

🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe